A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation.
作者信息
Armitage J M, Kormos R L, Griffith B P, Hardesty R L, Fricker F J, Stuart R S, Marrone G C, Todo S, Fung J, Starzl T E
机构信息
University of Pittsburgh School of Medicine, Department of Surgery, Pennsylvania.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 2):1149-52.
Abstract
摘要
相似文献
1
A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation.一项关于FK 506作为心脏移植主要及挽救性免疫抑制药物的临床试验。
Transplant Proc. 1991 Feb;23(1 Pt 2):1149-52.
2
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation.FK 506作为成人心脏移植主要及挽救性免疫抑制治疗的临床试验。
Transplant Proc. 1991 Dec;23(6):3054-7.
3
Use of FK 506 in pediatric patients.FK506在儿科患者中的应用。
Transplant Proc. 1991 Feb;23(1 Pt 2):924-7.
4
Kidney transplantation under FK 506 immunosuppression.在FK506免疫抑制下进行肾移植。
Transplant Proc. 1991 Feb;23(1 Pt 2):920-3.
5
The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation.FK 506作为小儿心脏移植主要和挽救性免疫抑制治疗的临床试验。
Transplant Proc. 1991 Dec;23(6):3058-60.
6
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506.FK506 作用下原位肝移植术后排斥反应的发生率及治疗情况
Transplant Proc. 1991 Feb;23(1 Pt 2):928-30.
7
Preliminary experience with FK506 in thoracic transplantation.
Transplantation. 1991 Jul;52(1):164-7. doi: 10.1097/00007890-199107000-00038.
8
The question of FK 506 nephrotoxicity after liver transplantation.肝移植后FK 506的肾毒性问题。
Transplant Proc. 1991 Feb;23(1 Pt 2):1444-7.
9
Clinical trial of FK 506 immunosuppression in adult cardiac transplantation.FK506免疫抑制在成人心脏移植中的临床试验。
Ann Thorac Surg. 1992 Aug;54(2):205-10; discussion 210-1. doi: 10.1016/0003-4975(92)91371-f.
10
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression.
Transplant Proc. 1995 Dec;27(6):3123-4.
引用本文的文献
1
A brief history of liver transplantation and transplant anesthesia.肝移植和移植麻醉的简史。
BMC Anesthesiol. 2022 Nov 26;22(1):363. doi: 10.1186/s12871-022-01904-1.
2
FKBP Ligands-Where We Are and Where to Go?FKBP配体——我们所处的位置与前进的方向？
Front Pharmacol. 2018 Dec 5;9:1425. doi: 10.3389/fphar.2018.01425. eCollection 2018.
3
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen.在以他克莫司作为基线免疫抑制方案的心脏移植术后头24个月内，具有更好的排斥反应情况。
Drug Des Devel Ther. 2014 Sep 9;8:1307-14. doi: 10.2147/DDDT.S68542. eCollection 2014.
4
History of clinical transplantation.临床移植史。
World J Surg. 2000 Jul;24(7):759-82. doi: 10.1007/s002680010124.
5
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.他克莫司（FK506）与制药/学术/监管的重重考验。
Am J Kidney Dis. 1998 Jun;31(6 Suppl 1):S7-14. doi: 10.1053/ajkd.1998.v31.pm9631858.
6
The current status of hepatic transplantation at the University of Pittsburgh.匹兹堡大学肝脏移植的现状
Clin Transpl. 1995:145-70.
7
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.他克莫司与环孢素用于肝移植的匹兹堡随机试验。
J Am Coll Surg. 1996 Aug;183(2):117-25.
8
Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion.肝移植受者持续静脉输注FK506后的药代动力学
J Clin Pharmacol. 1993 Jul;33(7):606-11. doi: 10.1002/j.1552-4604.1993.tb04712.x.
9
Adverse effects of FK 506 overdosage after liver transplantation.肝移植后FK 506过量的不良反应。
Transplant Proc. 1993 Feb;25(1 Pt 1):628-34.
10
A risk-benefit assessment of tacrolimus in transplantation.他克莫司在移植中的风险效益评估。
Drug Saf. 1995 May;12(5):348-57. doi: 10.2165/00002018-199512050-00006.
本文引用的文献
1
Infections after liver transplantation. An analysis of 101 consecutive cases.肝移植术后感染。101例连续病例分析。
Medicine (Baltimore). 1988 Mar;67(2):132-43. doi: 10.1097/00005792-198803000-00006.
2
FK 506 for liver, kidney, and pancreas transplantation.用于肝脏、肾脏和胰腺移植的FK 506。
Lancet. 1989 Oct 28;2(8670):1000-4. doi: 10.1016/s0140-6736(89)91014-3.
3
A highly sensitive method to assay FK-506 levels in plasma.一种检测血浆中FK-506水平的高灵敏度方法。
Transplant Proc. 1987 Oct;19(5 Suppl 6):23-9.
4
Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin.
Transplantation. 1990 Feb;49(2):306-11. doi: 10.1097/00007890-199002000-00016.
5
Kidney transplantation under FK 506.在使用FK506的情况下进行肾脏移植。
JAMA. 1990 Jul 4;264(1):63-7.
6
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.肝移植受者中因环孢素相关并发症而从环孢素转换为FK506治疗。
Transplant Proc. 1990 Feb;22(1):6-12.
7
Early trials with FK 506 as primary treatment in liver transplantation.FK506作为肝移植主要治疗手段的早期试验。
Transplant Proc. 1990 Feb;22(1):13-6.
Zotero 插件